Previous Close | 0.0700 |
Open | 0.0750 |
Bid | 0.0700 x N/A |
Ask | 0.0750 x N/A |
Day's Range | 0.0700 - 0.0750 |
52 Week Range | 0.0400 - 0.1500 |
Volume | |
Avg. Volume | 190,373 |
Market Cap | 28.213M |
Beta (5Y Monthly) | 1.67 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
TORONTO, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“Aleafia Health” or the “Company”) will now announce on Monday, February 13 prior to market open its fiscal year 2023 third quarter results for the period ending December 31, 2022. The Company will also host its earnings conference call the same day at 8:30 a.m. EST. The call will be hosted by CEO Tricia Symmes and CFO Matt Sale. CONFERENCE CALL & WEBCASTDate: February 13, 2023Time: 8:30 a.m. EST To view the
New Board Chair Also NamedTORONTO, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that it has signed a new European cannabis distribution partner, representing a one-year, approximately $1 million contract1, significantly bolstering the Company’s record $1.2 million year-to-date sales in its growing international channel. “This new announcement is very significant: it builds upon advancements made in August
Successful completion of TSX listing reviewExpansion of adult-use portfolio into key fifth province5 provinces now selling Aleafia’s adult-use products TORONTO, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Further to its previous announcements, Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that it has completed the TSX delisting review and confirms that the Company satisfies the Toronto Stock Exchange’s requirements for continued listing. Aleafia Hea